Order Article Reprints

Figueiredo J, Mercadillo F, Melo S, Barroso A, Gonçalves M, Díaz-Tasende J, Carneiro P, Robles L, Colina F, Ibarrola C, et al. Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden. Cancers. 2021; 13(17):4359. https://doi.org/10.3390/cancers13174359

Figueiredo, Joana, Fátima Mercadillo, Soraia Melo, Alicia Barroso, Margarida Gonçalves, José Díaz-Tasende, Patrícia Carneiro, Luis Robles, Francisco Colina, Carolina Ibarrola, and et al. 2021. "Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden" Cancers 13, no. 17: 4359. https://doi.org/10.3390/cancers13174359

Figueiredo, J., Mercadillo, F., Melo, S., Barroso, A., Gonçalves, M., Díaz-Tasende, J., Carneiro, P., Robles, L., Colina, F., Ibarrola, C., Perea, J., Morais-de-Sá, E., Seruca, R., & Urioste, M. (2021). Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden. Cancers, 13(17), 4359. https://doi.org/10.3390/cancers13174359